vs
Side-by-side financial comparison of DoubleDown Interactive Co., Ltd. (DDI) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
DoubleDown Interactive Co., Ltd. is the larger business by last-quarter revenue ($83.0M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 13.7%). DoubleDown Interactive Co., Ltd. produced more free cash flow last quarter ($31.6M vs $14.4M).
Take-Two Interactive Software, Inc. is an American video game holding company based in New York City founded by Ryan Brant in September 1993.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
DDI vs PBYI — Head-to-Head
Income Statement — Q3 FY2024 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $83.0M | $75.5M |
| Net Profit | $25.0M | — |
| Gross Margin | 70.1% | 69.3% |
| Operating Margin | 42.5% | 22.7% |
| Net Margin | 30.2% | — |
| Revenue YoY | 13.7% | 27.7% |
| Net Profit YoY | -7.0% | — |
| EPS (diluted) | $10.11 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | — | $54.5M | ||
| Q2 25 | — | $52.4M | ||
| Q1 25 | — | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | $83.0M | $80.5M | ||
| Q2 24 | $88.2M | $47.1M | ||
| Q1 24 | $88.1M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $25.0M | $20.3M | ||
| Q2 24 | $33.2M | $-4.5M | ||
| Q1 24 | $30.3M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | 70.1% | 63.9% | ||
| Q2 24 | 69.6% | 77.4% | ||
| Q1 24 | 68.9% | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | 42.5% | 27.4% | ||
| Q2 24 | 41.0% | -4.6% | ||
| Q1 24 | 35.2% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 16.2% | ||
| Q2 25 | — | 11.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 30.2% | 25.2% | ||
| Q2 24 | 37.6% | -9.6% | ||
| Q1 24 | 34.4% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | $10.11 | $0.41 | ||
| Q2 24 | $13.39 | $-0.09 | ||
| Q1 24 | $12.23 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $372.7M | $97.5M |
| Total DebtLower is stronger | $37.9M | $22.7M |
| Stockholders' EquityBook value | $815.5M | $130.3M |
| Total Assets | $879.8M | $216.3M |
| Debt / EquityLower = less leverage | 0.05× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | $372.7M | $96.7M | ||
| Q2 24 | $339.2M | $96.8M | ||
| Q1 24 | $309.5M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | $37.9M | $79.3M | ||
| Q2 24 | $36.0M | $90.7M | ||
| Q1 24 | $37.1M | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | — | $115.3M | ||
| Q2 25 | — | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | $815.5M | $71.1M | ||
| Q2 24 | $786.2M | $48.5M | ||
| Q1 24 | $755.2M | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | — | $202.9M | ||
| Q2 25 | — | $194.9M | ||
| Q1 25 | — | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | $879.8M | $220.7M | ||
| Q2 24 | $852.6M | $205.0M | ||
| Q1 24 | $831.0M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 0.05× | 1.12× | ||
| Q2 24 | 0.05× | 1.87× | ||
| Q1 24 | 0.05× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $31.8M | $14.4M |
| Free Cash FlowOCF − Capex | $31.6M | $14.4M |
| FCF MarginFCF / Revenue | 38.0% | 19.1% |
| Capex IntensityCapex / Revenue | 0.3% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | $129.5M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $31.8M | $11.0M | ||
| Q2 24 | $34.4M | $1.0M | ||
| Q1 24 | $34.9M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $31.6M | $11.0M | ||
| Q2 24 | $34.4M | $1.0M | ||
| Q1 24 | $34.9M | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | 38.0% | 13.7% | ||
| Q2 24 | 39.0% | 2.1% | ||
| Q1 24 | 39.6% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.27× | 0.54× | ||
| Q2 24 | 1.04× | — | ||
| Q1 24 | 1.15× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.